| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 5950807
[patent_doc_number] => 20020006418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-17
[patent_title] => 'COMPOSITION TO ENHANCE PERMEATION OF TOPICAL SKIN AGENTS'
[patent_app_type] => new
[patent_app_number] => 09/361426
[patent_app_country] => US
[patent_app_date] => 1999-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5375
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20020006418.pdf
[firstpage_image] =>[orig_patent_app_number] => 09361426
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/361426 | COMPOSITION TO ENHANCE PERMEATION OF TOPICAL SKIN AGENTS | Jul 26, 1999 | Abandoned |
Array
(
[id] => 4277684
[patent_doc_number] => 06281236
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Oil-in-water emulsion with improved stability'
[patent_app_type] => 1
[patent_app_number] => 9/360095
[patent_app_country] => US
[patent_app_date] => 1999-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4041
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/281/06281236.pdf
[firstpage_image] =>[orig_patent_app_number] => 360095
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/360095 | Oil-in-water emulsion with improved stability | Jul 22, 1999 | Issued |
Array
(
[id] => 1227249
[patent_doc_number] => 06696085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-24
[patent_title] => 'Use of an acrylic type polymer as disintegrating agent'
[patent_app_type] => B2
[patent_app_number] => 09/353646
[patent_app_country] => US
[patent_app_date] => 1999-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5734
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/696/06696085.pdf
[firstpage_image] =>[orig_patent_app_number] => 09353646
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/353646 | Use of an acrylic type polymer as disintegrating agent | Jul 14, 1999 | Issued |
Array
(
[id] => 6887644
[patent_doc_number] => 20010008638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-19
[patent_title] => 'NUTRITIONAL SUPPLEMENT COMPRISING AT LEAST ONE PROHORMONE AND AT LEAST ONE ANTI-ESTROGEN COMPOUND IN A TIME-RELEASE DOSAGE FORM'
[patent_app_type] => new-utility
[patent_app_number] => 09/352084
[patent_app_country] => US
[patent_app_date] => 1999-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5022
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20010008638.pdf
[firstpage_image] =>[orig_patent_app_number] => 09352084
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/352084 | NUTRITIONAL SUPPLEMENT COMPRISING AT LEAST ONE PROHORMONE AND AT LEAST ONE ANTI-ESTROGEN COMPOUND IN A TIME-RELEASE DOSAGE FORM | Jul 13, 1999 | Abandoned |
Array
(
[id] => 697855
[patent_doc_number] => 07067109
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-06-27
[patent_title] => 'Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids'
[patent_app_type] => utility
[patent_app_number] => 09/351149
[patent_app_country] => US
[patent_app_date] => 1999-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 70488
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067109.pdf
[firstpage_image] =>[orig_patent_app_number] => 09351149
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/351149 | Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids | Jul 11, 1999 | Issued |
| 09/214047 | PHARMACEUTICAL ADMINISTRATION FORM | Jul 11, 1999 | Abandoned |
Array
(
[id] => 1263395
[patent_doc_number] => 06660278
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-09
[patent_title] => 'Controlled release composition'
[patent_app_type] => B1
[patent_app_number] => 09/341294
[patent_app_country] => US
[patent_app_date] => 1999-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3946
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/660/06660278.pdf
[firstpage_image] =>[orig_patent_app_number] => 09341294
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/341294 | Controlled release composition | Jul 7, 1999 | Issued |
Array
(
[id] => 6474989
[patent_doc_number] => 20020151599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'FORMULATIONS HAVING AN ANTIVIRAL ACTION'
[patent_app_type] => new
[patent_app_number] => 09/349713
[patent_app_country] => US
[patent_app_date] => 1999-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3505
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151599.pdf
[firstpage_image] =>[orig_patent_app_number] => 09349713
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/349713 | FORMULATIONS HAVING AN ANTIVIRAL ACTION | Jul 7, 1999 | Abandoned |
Array
(
[id] => 1415487
[patent_doc_number] => 06506391
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-14
[patent_title] => 'Cosmetic or dermatological composition in the form of a dispersion of an oily phase and an aqueous phase, stabilized with cubic gel particles'
[patent_app_type] => B1
[patent_app_number] => 09/347101
[patent_app_country] => US
[patent_app_date] => 1999-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4472
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/506/06506391.pdf
[firstpage_image] =>[orig_patent_app_number] => 09347101
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/347101 | Cosmetic or dermatological composition in the form of a dispersion of an oily phase and an aqueous phase, stabilized with cubic gel particles | Jul 1, 1999 | Issued |
Array
(
[id] => 1586453
[patent_doc_number] => 06359006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-03-19
[patent_title] => 'Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications'
[patent_app_type] => B2
[patent_app_number] => 09/344850
[patent_app_country] => US
[patent_app_date] => 1999-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9923
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/359/06359006.pdf
[firstpage_image] =>[orig_patent_app_number] => 09344850
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/344850 | Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications | Jun 27, 1999 | Issued |
Array
(
[id] => 1433166
[patent_doc_number] => 06340455
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-22
[patent_title] => 'Testkit and method'
[patent_app_type] => B1
[patent_app_number] => 09/308365
[patent_app_country] => US
[patent_app_date] => 1999-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2036
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/340/06340455.pdf
[firstpage_image] =>[orig_patent_app_number] => 09308365
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/308365 | Testkit and method | Jun 22, 1999 | Issued |
Array
(
[id] => 1275734
[patent_doc_number] => 06645508
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-11
[patent_title] => 'Stable L-ascorbic acid composition'
[patent_app_type] => B1
[patent_app_number] => 09/336193
[patent_app_country] => US
[patent_app_date] => 1999-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5366
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/645/06645508.pdf
[firstpage_image] =>[orig_patent_app_number] => 09336193
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/336193 | Stable L-ascorbic acid composition | Jun 17, 1999 | Issued |
Array
(
[id] => 4417114
[patent_doc_number] => 06177101
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-23
[patent_title] => 'Delavirdine high strength tablet formulation'
[patent_app_type] => 1
[patent_app_number] => 9/327135
[patent_app_country] => US
[patent_app_date] => 1999-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2509
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/177/06177101.pdf
[firstpage_image] =>[orig_patent_app_number] => 327135
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/327135 | Delavirdine high strength tablet formulation | Jun 6, 1999 | Issued |
| 09/322138 | NATURALLY-DERIVED ANTI-INFLAMMATORY AGENTS AND METHODS FOR THEIR PREPARATION AND USE | May 27, 1999 | Abandoned |
Array
(
[id] => 1213230
[patent_doc_number] => 06710082
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-23
[patent_title] => 'Use of hydroxycarboxylic acid esters as thickeners'
[patent_app_type] => B1
[patent_app_number] => 09/194824
[patent_app_country] => US
[patent_app_date] => 1999-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4213
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/710/06710082.pdf
[firstpage_image] =>[orig_patent_app_number] => 09194824
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/194824 | Use of hydroxycarboxylic acid esters as thickeners | May 24, 1999 | Issued |
Array
(
[id] => 4342717
[patent_doc_number] => 06214343
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Prevention and treatment of necrotizing enterocolitis'
[patent_app_type] => 1
[patent_app_number] => 9/318109
[patent_app_country] => US
[patent_app_date] => 1999-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8035
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214343.pdf
[firstpage_image] =>[orig_patent_app_number] => 318109
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/318109 | Prevention and treatment of necrotizing enterocolitis | May 23, 1999 | Issued |
Array
(
[id] => 1208452
[patent_doc_number] => 06713083
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-30
[patent_title] => 'Coated bioabsorbable beads for wound treatment'
[patent_app_type] => B1
[patent_app_number] => 09/142814
[patent_app_country] => US
[patent_app_date] => 1999-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2239
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/713/06713083.pdf
[firstpage_image] =>[orig_patent_app_number] => 09142814
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/142814 | Coated bioabsorbable beads for wound treatment | May 20, 1999 | Issued |
| 09/316426 | TOPICAL OINTMENT | May 20, 1999 | Abandoned |
| 09/242647 | DIAGNOSIS OF MIGRAINE WITH AURA, DEPRESSION AND ANXIETY FROM ALLELIC VARIATIONS IN DOPAMINERGIC GENES | May 19, 1999 | Abandoned |
Array
(
[id] => 7027848
[patent_doc_number] => 20010014352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-16
[patent_title] => 'COMPRESSED TABLET FORMULATION'
[patent_app_type] => new
[patent_app_number] => 09/312617
[patent_app_country] => US
[patent_app_date] => 1999-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4740
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20010014352.pdf
[firstpage_image] =>[orig_patent_app_number] => 09312617
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/312617 | COMPRESSED TABLET FORMULATION | May 16, 1999 | Abandoned |